HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Martin Tepel Selected Research

1-oleoyl-2-acetylglycerol

10/2007Monocytes from spontaneously hypertensive rats show increased store-operated and second messenger-operated calcium influx mediated by transient receptor potential canonical Type 3 channels.
4/2007Increased store-operated and 1-oleoyl-2-acetyl-sn-glycerol-induced calcium influx in monocytes is mediated by transient receptor potential canonical channels in human essential hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Martin Tepel Research Topics

Disease

14Chronic Renal Insufficiency
11/2019 - 01/2007
13Chronic Kidney Failure (Chronic Renal Failure)
01/2022 - 03/2002
11Hypertension (High Blood Pressure)
08/2011 - 03/2002
6Atherosclerosis
07/2014 - 03/2002
5Cardiovascular Diseases (Cardiovascular Disease)
07/2014 - 02/2003
5Essential Hypertension
01/2012 - 11/2005
4Kidney Diseases (Kidney Disease)
01/2022 - 03/2009
4Alzheimer Disease (Alzheimer's Disease)
01/2022 - 12/2009
4Fibrosis (Cirrhosis)
11/2019 - 01/2013
4Type 2 Diabetes Mellitus (MODY)
01/2018 - 04/2008
4Inflammation (Inflammations)
10/2015 - 05/2003
3Delayed Graft Function
01/2022 - 01/2015
3Diabetic Nephropathies (Diabetic Nephropathy)
01/2020 - 03/2012
3Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2008 - 02/2006
3Cardiomegaly (Heart Hypertrophy)
12/2007 - 01/2004
2Hyperglycemia
01/2022 - 04/2008
2Disease Progression
11/2019 - 12/2017
2Infections
01/2019 - 06/2007
2Renal Insufficiency (Renal Failure)
01/2013 - 09/2002
2Obesity
04/2010 - 04/2007
2Insulin Resistance
03/2009 - 12/2008
2Neoplasms (Cancer)
11/2008 - 06/2007
2Critical Illness (Critically Ill)
01/2008 - 05/2003
2Vascular Diseases (Vascular Disease)
10/2007 - 03/2002
2Stroke (Strokes)
02/2004 - 05/2003
2Myocardial Infarction
02/2003 - 01/2002
1Dementia (Dementias)
01/2022
1Hypoglycemia (Reactive Hypoglycemia)
01/2022
1Mitochondrial Diseases (Mitochondrial Disease)
01/2022
1Cognitive Dysfunction
01/2022
1Vascular Remodeling
01/2022
1Viremia
12/2020
1Prostatic Neoplasms (Prostate Cancer)
11/2019
1Uremia
01/2017
1Reperfusion Injury
01/2015
1Atherosclerotic Plaque (Atheroma)
07/2014
1Glucose Intolerance
07/2014
1Dyslipidemias (Dyslipidemia)
07/2014

Drug/Important Bio-Agent (IBA)

11TRPC6 Cation ChannelIBA
01/2022 - 04/2007
10CalciumIBA
10/2011 - 11/2002
6Proteins (Proteins, Gene)FDA Link
01/2017 - 12/2005
5CationsIBA
04/2010 - 06/2006
5Acetylcysteine (Siran)FDA LinkGeneric
01/2009 - 09/2002
4LipidsIBA
07/2014 - 11/2008
4Messenger RNA (mRNA)IBA
03/2012 - 08/2004
4Transient Receptor Potential ChannelsIBA
01/2012 - 06/2006
3Glucose (Dextrose)FDA LinkGeneric
01/2022 - 04/2008
3Collagen Type VIIBA
01/2022 - 12/2017
3Retinol-Binding Proteins (Retinoid Binding Proteins)IBA
02/2010 - 08/2008
2endotrophinIBA
01/2022 - 12/2017
2oxidized low density lipoproteinIBA
01/2022 - 07/2014
2Blood Proteins (Serum Proteins)IBA
01/2022 - 10/2015
2CreatinineIBA
01/2022 - 12/2017
2Actins (F Actin)IBA
12/2020 - 12/2005
2CollagenIBA
11/2019 - 01/2018
2C-Reactive ProteinIBA
10/2015 - 12/2007
2Hormones (Hormone)IBA
01/2013 - 05/2003
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2012 - 03/2008
2Biomarkers (Surrogate Marker)IBA
02/2012 - 12/2009
2TRPC3 cation channelIBA
10/2011 - 10/2007
2Capsaicin (Zostrix)FDA Link
08/2010 - 04/2007
2PPAR deltaIBA
04/2010 - 03/2007
2Protein Isoforms (Isoforms)IBA
03/2009 - 08/2008
2DNA (Deoxyribonucleic Acid)IBA
11/2008 - 12/2005
2Fluorescent Dyes (Fluorescent Probes)IBA
04/2008 - 04/2007
2LeptinIBA
11/2007 - 06/2007
21-oleoyl-2-acetylglycerolIBA
10/2007 - 04/2007
2HomocysteineIBA
11/2004 - 01/2004
2SodiumIBA
08/2004 - 01/2004
2Angiotensin IIIBA
08/2004 - 01/2004
2AntioxidantsIBA
01/2004 - 02/2003
1AlbuminsIBA
01/2022
1Hemoglobin CIBA
01/2022
1Insulin (Novolin)FDA Link
01/2022
1LDL Lipoproteins (beta Lipoproteins)IBA
01/2022
1Parathyroid Hormone (Parathormone)IBA
01/2022
1Streptozocin (Streptozotocin)FDA Link
01/2022
1Angiopoietin-2IBA
01/2022
1Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
01/2022
1Long Noncoding RNAIBA
12/2020
1NADP (NADPH)IBA
01/2020
1Extracellular Matrix ProteinsIBA
11/2019
1eculizumabFDA Link
01/2019
1AntigensIBA
11/2018
1Golgi Matrix ProteinsIBA
11/2018
1AntibodiesIBA
11/2018
1Monoclonal AntibodiesIBA
11/2018
1superoxide dismutase 2IBA
01/2016
1ProteomeIBA
10/2015
1Interleukin-8 (Interleukin 8)IBA
01/2015
1Lipoproteins (Lipoprotein)IBA
07/2014
1HDL LipoproteinsIBA
07/2014

Therapy/Procedure

14Renal Dialysis (Hemodialysis)
01/2022 - 01/2002
5Therapeutics
11/2007 - 03/2002
4Kidney Transplantation
01/2022 - 08/2005
4Transplantation
12/2020 - 01/2012
2Intravenous Administration
01/2009 - 01/2004
2Catheters
01/2008 - 05/2003
2Oral Administration
04/2007 - 09/2002
1Glycemic Control
01/2022